NOVEL DRUG FOR THE INHIBITION, PREVENTION OR TREATMENT OF RHEUMATOID ARTHRITIS.

摘要

The present invention relates to the use of at least one interleukin 17F inhibitor and / or at least one IL17 receptor inhibitor, for the preparation of a medicament for inhibition, The invention also relates to a pharmaceutical composition comprising as active substance at least one interleukin 17F inhibitor and / or at least one inhibitor of an IL17 receptor in combination with a pharmaceutically appropriate carrier, as well as its use for the inhibition, prevention or treatment of rheumatoid arthritis.